Research and Market Structure: Evidence from an Antibiotic-Resistant Pathogenic Outbreak

We thank Frederique Bone, Xavier Castaner, Adrian Ely, Philippe Gorry, Dietmar Harhoff, Jeremy Hall, Michael Hopkins, Bruce Hollingsworth, Katharina Janke, Gerard Llobet, Ben Martin, Catalina Martinez, Ceu Mateus, Ed Steinmueller and Simone Vanuccini as well as seminar participants at Lancaster University, HEC Lausanne and Mercados, Innovación y Medio Ambiente - Comunidad de Madrid, Max Planck Institute for Innovation and Competition and Freeman Seminar Series at SPRU-Sussex for helpful comments and suggestions. We thank IMS Health Incorporated, now IQVIA, for their generous support and access to their data. The statements, findings, conclusions, views, and opinions contained and expressed herein are not necessarily those of IQVIA, IMS Health Incorporated, the National Bureau of Economic Research, or any of its affiliated or subsidiary entities. The statements, findings, conclusions, views, and opinions contained and expressed in this article are based in part on data obtained under license from the following IMS Health Incorporated or affiliate information service(s): IMS Midas™. Chatterjee acknowledges support of the Campbell and Edward Teller National Fellowship, the Visiting Fellow program at the Hoover Institution, Stanford University and the ICICI Bank Chair in Strategic Management, IIM Ahmedabad. Higgins acknowledges support from the Sorenson Center for Discovery and Innovation. Authors are listed alphabetically, and the usual disclaimers apply.

• May 19, 2021